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Schizophrenia is associated with heterogeneous course of positive and negative symp-
toms. In addition, reduced motor activity as measured by wrist actigraphy has been
reported. However, longitudinal studies of spontaneous motor activity are missing. We
aimed to explore whether activity levels were stable within and between psychotic
episodes. Furthermore, we investigated the association with the course of negative symp-
toms. In 45medicated patients,we investigatedmotor behaviorwithin a psychotic episode.
In addition, we followed 18 medicated patients across 2 episodes. Wrist actigraphy and
psychopathological ratings were applied.Within an episode symptoms changed but activ-
ity levels did not vary systematically. Activity at baseline predicted the course of negative
symptoms. Between two episodes activity recordings were much more stable. Again,
activity at the index episode predicted the outcome of negative symptoms. In sum, spon-
taneous motor activity shares trait and state characteristics, the latter are associated with
negative symptom course. Actigraphy may therefore become an important ambulatory
instrument to monitor negative symptoms and treatment outcome in schizophrenia.
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INTRODUCTION
Schizophrenia is characterized by positive symptoms, nega-
tive symptoms, and disorganization. Furthermore, cognitive and
motor symptoms have been identified as relevant symptom clus-
ters of schizophrenia. In fact, the current DSM5 concept of
psychoses proposed eight dimensions of psychopathology to be
assessed in subjects with schizophrenia, including motor symp-
toms (1). Schizophrenia is further associated with particular het-
erogeneity in course and outcome (2, 3). Generally, symptoms
ameliorate during the course of a psychotic episode; however, neg-
ative symptoms do not respond as well to treatment as positive
symptoms and disorganization too (4, 5). In longitudinal stud-
ies over years, negative symptoms generally tend to be stable (5,
6). However, findings of a recent meta-analysis suggest that neg-
ative symptoms may improve to a greater extent than what has
previously been assumed (7).
Motor signs in schizophrenia include catatonia, neurological
soft signs, psychomotor slowing, and extrapyramidal symptoms,
i.e., abnormal involuntary movements, akathisia, and parkinson-
ism (8, 9). These motor symptoms are prevalent throughout the
course of the disorder and may be affected by antipsychotic treat-
ment. Particularly, gross motor behavior is important in schizo-
phrenia; it is linked with medication, symptom dimensions, and
relevant for physical health (10, 11). Spontaneous motor activ-
ity may be objectively assessed with continuous wrist actigraphy
(12). A number of parameters can be calculated from actigraphy
data, such as the activity level (AL; activity counts per hour), the
movement index (MI; percentage of active periods), or the aver-
age duration of immobility periods (12). However, it was the AL
that was associated with negative syndrome severity (13–15) and
neuroimaging markers (16–18). In general, schizophrenia patients
have reduced levels of daytime activity compared to healthy con-
trol subjects (15, 17, 19, 20). One study performed actigraphic
recordings for seven consecutive days (19). Their graphs indicate
rather stable measurements throughout a week, even though no
statistical test had been applied to explore temporal fluctuations.
Actigraphy has been used for cross-sectional comparisons of spon-
taneous motor behavior in schizophrenia; however, no study has
addressed the longitudinal course within or even between psy-
chotic episodes. Studies on motor abnormalities in first episode
and chronic schizophrenia indicate that most motor symptoms
including hypokinesia are attenuated by antipsychotic treatment
within 4 weeks (21, 22). Therefore, we could assume that sponta-
neous motor activity is subject to changes within an episode. The
longitudinal course of motor signs over more than a few weeks
has only rarely been addressed. Few longitudinal studies included
finger tapping and found no changes over time (23). Docx et al.
report amelioration of catatonia and neurological soft signs in sta-
ble patients over 1 year (24). Likewise, neurological soft signs tend
to decrease within the first year in schizophrenia (25).
The current study aimed at testing whether spontaneous motor
activity would change during the course of a psychotic episode as
well as during the course between two psychotic episodes. Fur-
thermore, we wanted to investigate whether spontaneous motor
activity at baseline would predict the course of symptoms in schiz-
ophrenia. The literature suggests wide distribution of activity levels
between subjects with schizophrenia (15, 17). We hypothesized
that a considerable proportion of the variance was stable over
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time (trait motor activity) and that some of the variable motor
activity was state dependent and linked to negative symptoms of
schizophrenia.
MATERIALS AND METHODS
PARTICIPANTS
Participants were recruited from the inpatient and outpatient
department of the University Hospital of Psychiatry, Bern, Switzer-
land. This investigation includes data from three different studies
that all used the same actigraphy procedures. Diagnoses were given
after thorough clinical examination and review of all case files by
board certified psychiatrists. The local mental health care system
ensures that most of the patients are admitted to our clinic in
every psychotic episode requiring inpatient treatment, allowing
the collection of reliable diagnostic information. In a proportion
of studies that contributed data to this analysis, the diagnoses
were ascertained by structured clinical interviews (both SCID and
MINI; 27% of cases). Patients were excluded in case of substance
abuse other than nicotine, medical conditions affecting physical
activity (e.g., injuries such as fractures or ligament ruptures and
conditions such as idiopathic parkinsonism, arthrosis, or rheuma-
tism) and epilepsy. Physical activity was recorded approximately
2 weeks after admission to the psychiatric department (24 h at each
assessment time point). At the same time, psychopathology was
assessed using the positive and negative syndrome scale (PANSS)
(20). In the within-episode sample, actigraphy and PANSS assess-
ments were repeated after the acute symptoms had been allevi-
ated. In the between episodes sample, assessments were repeated
within the first 2 weeks of the subsequent inpatient treatment due
to a psychotic episode. Episode and inter-episode interval have
been defined according the practice guidelines developed by the
American Psychiatric Association codified a three-phase model
of schizophrenia disease course, with the recognition that these
phases“merge into one another without absolute, clear boundaries
between them” (26). According to this model, the “acute phase,”
characterized by florid psychosis and severe positive and/or nega-
tive symptoms, which is followed by a “stabilization phase,” during
which symptoms recede and decrease in severity, and a subsequent
“stable phase” with reduced symptom severity and relative symp-
tom stability. In detail, the stable phase reflects the inter-episode
interval while the acute phase including the stabilization phase
has been defined as episode and within-episode interval (26, 27).
Chlorpromazine equivalents (CPZ) of the current antipsychotic
pharmacotherapy were calculated according to Woods (21). The
protocols of the studies applying wrist actigraphy in schizophrenia
spectrum disorders had been approved by the local ethics commit-
tee and participants provided written informed consent prior to
study inclusion.
Within-episodes sample
In total, 45 patients (28 men and 15 women) were included with
an average period between measurements of 42 days. Mean age
was 36.9± 9.5 years, mean duration of illness 11.1± 10.7 years.
Patients experienced 6.8± 6.6 episodes. The majority was treated
with antipsychotics (94%; aripiprazole, clozapine, quetiapine,
risperidone, olanzapine, haloperidol, amisulpride, zuclopenthixol,
and flupenthixol), most of them atypical (91%).
Between episodes sample
In total, 18 patients (13 men and 5 women) were included with
an average period between episodes of 639 days (4 subjects of the
within-episode sample were also included in the between episode
sample). Mean age was 34.7± 10.5 years, mean duration of ill-
ness 8.7± 8.0 years. Patients experienced 6.9± 7.2 episodes. All
patients received antipsychotic treatment (aripiprazole, clozapine,
quetiapine, risperidone,olanzapine,haloperidol, and amisulpride)
with predominantly atypical antipsychotics (index episode 83%,
later episode 94%).
ACTIGRAPHY
Participants wore an actigraph (Actiwatch, Cambridge Neurotech-
nology, Inc., Cambridge, UK) for 24 consecutive hours at the wrist
of the non-dominant arm. The piezoelectronic sensor converts
acceleration into movement counts. Data were sampled in 2 s
intervals. Participants provided sleep log information and infor-
mation on recording pauses (due to showering or bathing). Only
the data collected during wakeful periods of the 24 h recording
time were analyzed. Activity counts were averaged to provide the
AL in counts/h.
STATISTICAL ANALYSES
Positive and negative syndrome scale scores were used to calcu-
late two factors of negative symptoms as in previous studies (15,
28, 29): the expressivity factor including items N1 (blunted affect)
and N6 (lack of spontaneity and flow of conversation) and the
avolition factor including items N2 (emotional withdrawal) and
N4 (passive/apathetic social withdrawal). Longitudinal compar-
isons of clinical and actigraphic parameters were calculated using
paired T -tests. To test the explained variance, we entered AL base-
line as predictor of a linear regression model of AL post. In both
cohorts, we detected wide variability of AL changes. Using Pear-
son correlations, we explored associations between AL at baseline
and clinical parameters at baseline and in the longitudinal course.
Next, we aimed at testing groups according to their baseline AL
values. In order to test the longitudinal course of PANSS scores
according to baseline motor activity, we defined groups applying
the 33rd and 66th percentile of the baseline AL in both cohorts.
Group comparisons (low, medium, and high AL) were conducted
using repeated measures ANOVAs. Post hoc analyses were Sidak
corrected for multiple comparisons. All analyses were conducted
with SPSS22.
RESULTS
WITHIN EPISODES
Within psychotic episodes longitudinal AL changes were wide-
ranged. Paired T -tests of AL baseline and AL post indicated no
change (see Table 1). However, only 28% of the patients had stable
AL, i.e., AL changed by <20%. AL post ranged 35–272% of the
AL at baseline. In contrast, PANSS positive and PANSS total scores
were attenuated, a trend for improvement was detected in PANSS
negative scores (see Table 1). Interestingly, baseline AL inversely
correlated at trend level with% of change of activity (r =−0.286;
p= 0.063), indicating that the less patients move at baseline the
more likely AL changes within episodes. However, the magnitude
of change from baseline AL was not predictive of the longitudinal
course of PANSS scores (r-range:−0.17–0.10).
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Table 1 | PairedT -tests within episode.
Baseline Post T df p r
AL (counts/h) 13735±7274 13544±8128 0.2 42 0.870 0.52
PANSS positive 17.1±5.8 13.1±4.8 4.3 42 <0.001 0.34
PANSS negative 18.4±6.8 16.4±6.2 1.7 42 0.099 0.30
PANSS avolition 5.3±2.2 4.9±2.4 0.8 42 0.406 0.10
PANSS expressivity 5.5±3.0 5.0±2.3 1.4 42 0.181 0.56
PANSS total 69.5±16.6 59.0±15.9 3.4 42 0.001 0.24
CPZ (mg) 543±401 531±435 0.2 42 0.807 0.69
Table 2 | Repeated measures ANOVAs within episode.
AL baseline group Time Group Time×group
Low Medium High F p F p F p
AL Baseline 7742±1178 11077±1469 22577±6016 0.3 0.863 47.2 <0.001 0.8 0.455
Post 9096±4684 11329±4174 20366±9781
PANSS positive Baseline 14.5±4.9 19.5±6.1 17.3±5.7 17.7 <0.001 5.1 0.011 0.03 0.967
Post 10.8±3.6 15.3±5.0 13.0±4.8
PANSS negative Baseline 21.9±6.9 19.3±5.6 13.9±5.7 3.3 0.078 4.1 0.025 3.5 0.039
Post 15.8±5.7 18.5±7.4 14.8±5.2
PANSS avolition Baseline 6.2±2.6 5.6±1.9 4.1±1.6 0.9 0.357 1.5 0.230 4.5 0.017
Post 4.0±2.3 5.7±2.4 5.0±2.3
PANSS expressivity Baseline 7.5±3.0 5.3±2.8 3.7±2.0 2.3 0.134 5.2 0.010 4.8 0.014
Post 5.4±2.2 5.5±2.7 3.9±1.9
PANSS total Baseline 69.8±12.9 76.9±20.5 61.4±11.7 11.9 0.001 4.6 0.016 1.1 0.339
Post 53.6±15.4 66.2±16.0 56.6±14.3
AL: high> low (p< 0.001) and high>medium (p< 0.001) post hoc Sidak tests.
Activity level at baseline predicted AL post (R2= 0.26,F = 15.0,
p< 0.001). AL baseline correlated with PANSS negative base-
line (r =−0.53, p< 0.001). Furthermore, AL post correlated with
PANSS negative at both time points (PANSS negative baseline:
r =−0.39, p= 0.011; PANSS negative post: r =−0.35, p= 0.021).
Therefore, we explored whether AL baseline would indicate lon-
gitudinal changes in psychopathology. AL baseline was used to
define three groups based on percentile rankings (33rd and 66th
percentiles), i.e., low, medium, and high AL baseline. The three
patient groups did not differ in terms of age (F = 1.3, df= 2,
p= 0.294), duration of illness (F = 1.4, df= 2, p= 0.258), num-
ber of episodes (F = 1.2, df= 2, p= 0.311), CPZ (F = 0.01, df= 2,
p= 0.992), and the time between measurements (F = 0.5, df= 2,
p= 0.609). Time effects were strong for PANSS positive and total
scores, indicating attenuation of symptoms during the episode
(see Table 2; Figure 1). Significant group× time interactions were
detected only for the measures of the negative syndrome: PANSS
negative scores, avolition, and expressivity scores decreased sig-
nificantly only in the group with low AL at baseline (T = 3.4,
p= 0.005; T = 2.7, p= 0.019; T = 3.2, p= 0.006), while in the
other groups negative syndrome scores remained stable.
BETWEEN EPISODES
Between episodes, AL was more stable than within episodes. In
fact, 50% of the patients had AL changes of ±20%. AL at the
later episode ranged 40–167% of AL at the index episode. Like-
wise, PANSS scores were similar between episodes (see Table 3),
except a trend for deterioration in the PANSS avolition score.
AL at index episode predicted AL at the later episode (R2= 0.65,
F = 30.0, p< 0.001). Neither AL at index episode nor AL at a later
episode correlated significantly with PANSS scores. Still, when the
group was divided according to AL at index episode (low, medium,
high AL), we detected a significant group effect on PANSS nega-
tive scores, as well as a trend to a time× group interaction (see
Table 4; Figure 2). Negative syndrome scores increased between
episodes in patients with high AL at index episode (T =−2.6,
p= 0.047) and at trend level also in patients with low AL at index
episode (T =−2.1,p= 0.095). Likewise, avolition scores increased
at trend level in the group with high AL at index episode (T =−2.7,
p= 0.052). In the group with low AL at index episode, we found
single PANSS negative items to increase over time at trend level:
N1 (blunted affect, p= 0.076) and N3 (poor rapport, p= 0.076).
In the group with high AL at index episode, we found trends for
changes of the items N2 (emotional withdrawal, p= 0.070) and
N6 (lack of spontaneity, p= 0.070).
DISCUSSION
The present study explored the longitudinal course of spontaneous
motor activity in schizophrenia. Results indicate considerable vari-
ance within psychotic episodes and stability of activity levels
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FIGURE 1 |Within-episode course of activity and psychopathology (n=45) lines indicate mean±SE.
Table 3 | PairedT -tests between episodes.
Index episode Later episode T df p r
AL (counts/h) 15472±10152 13591±7474 1.3 17 0.203 0.81
PANSS positive 13.3±5.1 14.6±6.0 −1.4 17 0.183 0.77
PANSS negative 17.7±7.6 19.6±7.7 −1.1 17 0.274 0.67
PANSS avolition 4.1±2.0 5.5±3.2 −2.1 17 0.051 0.53
PANSS expressivity 5.5±3.1 6.1±2.9 −1.0 17 0.351 0.69
PANSS total 60.0±16.1 65.4±16.1 −1.2 17 0.253 0.29
CPZ (mg) 440±305 608±387 −1.8 17 0.092 0.36
Table 4 | Repeated measures ANOVA between episodes (n=18).
AL index group Time Group Time×group
Low Medium High F p F p F p
AL Index 6870±1669 13241±2623 26305±10256 2.4 0.143 13.0 0.001 4.1 0.038
Later 7263±3211 14016±4016 19495±8567
PANSS positive Index 15.5±7.3 11.8±3.8 12.7±3.6 1.9 0.189 0.7 0.522 0.86 0.442
Later 15.8±5.4 12.3±6.4 15.7±6.7
PANSS negative Index 17.7±7.9 17.2±7.4 18.2±8.9 1.6 0.231 4.1 0.025 2.9 0.088
Later 22.0±9.3 14.3±2.3 21.7±8.1
PANSS avolition Index 4.7±2.7 4.0±2.0 3.4±0.9 4.8 0.047 0.6 0.539 1.7 0.217
Later 6.3±4.1 3.8±2.0 6.2±2.7
PANSS expressivity Index 5.5±2.9 5.8±3.0 5.2±3.8 0.8 0.396 0.1 0.880 1.4 0.273
Later 7.0±3.6 5.0±1.2 6.0±3.4
PANSS total Index 62.3±17.9 55.3±17.5 62.3±15.3 1.3 0.275 1.5 0.264 0.3 0.751
Later 69.5±15.4 55.7±13.7 71.0±16.9
AL: high> low (p<0.001) and high>medium (p=0.028) post hoc Sidak tests.
between episodes. Furthermore, within-episodes baseline activity
predicted the outcome of negative symptom severity. Therefore,
our hypotheses were confirmed: spontaneous motor activity in
schizophrenia has trait and state characteristics; the latter are
associated with the negative syndrome.
WITHIN-EPISODE VARIANCE
Activity levels for the whole group demonstrated considerable
variance, only 26% of the variance of AL post were predicted
by AL at baseline. When we split the sample into three similar
sized groups according to the baseline AL, we found no changes
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FIGURE 2 | Between episode course of activity and psychopathology (n=18) lines indicate mean±SE.
over time; instead, group differences remained throughout the
episode. This stability of motor activity is congruent with the
observations over 1 week (19). However, other motor signs in
schizophrenia are attenuated by antipsychotic treatment. This is
true for abnormal involuntary movements and neurological soft
signs but also for hypokinesia, parkinsonism, and catatonia (21,
22, 25). Particularly, when hypokinetic movement disorders were
ameliorated, we could expect an increase in AL within an episode.
Our findings fail to support this notion. As noted above, there
was considerable variance in the longitudinal course of AL within
an episode. Peralta and Cuesta reported in their sample of 100
unmedicated first episode patients that 21% had parkinsonism
and 18% catatonia at baseline (30). The two hypokinetic move-
ment disorders demonstrated distinct courses with antipsychotic
treatment; parkinsonism increased and catatonia declined within
4 weeks. Interestingly, for both syndromes, cases were identified
who had drug emergent, drug responsive, and drug irresponsive
courses (30). Therefore, patients can present with very different
courses of movement disorders, which may explain our finding of
stable AL in the paired T -test and only 26% of explained variance
between assessments.
Activity level at baseline separated the groups according to
negative syndrome severity. As in previous studies, lower AL was
associated with increased negative syndrome scores (13–15). Fur-
thermore, the groups differed in the course of negative syndrome.
Patients in the low AL group experienced a pronounced decrease
of negative syndrome scores within the episode, while the other
groups did not. This finding was true for both, the avolition
and the expressivity component of the PANSS negative syndrome
score. Baseline AL may therefore predict who will have a higher
probability of reduced negative symptoms with treatment. In
line with the literature, within episodes in general PANSS pos-
itive and total scores decreased more than negative scores with
antipsychotic treatment (4, 5, 31). In contrast, the avolition score
remained stable (5, 32). Therefore, avolition may represent the
invariant component of negative symptoms while other negative
symptoms tend to improve (32). Interestingly, specifically deficits
of “action-orientation” (slowing of the initiation of fine motor
movements) have been associated with avolition (29). Likewise,
problems of initiation of goal directed behavior might have led to
psychomotor slowing in our study. Avolition is a critical com-
ponent of the negative syndrome in schizophrenia, linked to
impaired motivation and poor functional outcome (33). Mea-
sures of avolition are correlated with reduced AL in schizophrenia
(15, 34). Because actigraphy is a well-accepted, ambulatory, and
non-invasive way of obtaining objective data on spontaneous
movement, it should be applied in larger pharmaceutical trials
on negative symptoms in schizophrenia. At the very least, it could
help to identify subjects at baseline with increased likelihood of
responding to treatments for negative symptoms.
BETWEEN EPISODES STABILITY
Between two psychotic episodes AL was much more stable (65%
explained variance) than within an episode. The time× group
interaction indicated regression to the mean for AL in the lon-
gitudinal course. Our results argue for a trait component in AL
in schizophrenia. Data on the long-term course of other motor
phenomena are scarce and produced mixed results. Studies on
neurological soft signs found subjects with increasing and subjects
with decreasing symptoms (24, 25). The patients with increas-
ing soft signs had poorer overall outcome (25). Catatonia was
found to be reduced within 1 year even in chronic schizophrenia,
but parkinsonism and motor retardation were unchanged (24). In
contrast, cross-sectional reports of motor function in schizophre-
nia (chronic vs. first episode) noted generalized deterioration with
ongoing course (35). Still, longitudinal studies of motor behavior
during multiple episodes are missing.
Long-term studies starting in the first psychotic episodes indi-
cate that considerable proportions of negative symptoms remain
unchanged over several years (5, 6, 32). Again, avolition was most
stable among the negative symptoms (5, 32). In our study, both
positive and negative symptom scores displayed no time effect
in the whole group, which may be accounted for by the small
sample size. Still, correlations between index and later episode
were strong for both syndromes. However, the avolition score
indicated overall deterioration of this component of negative
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symptoms. In patients with high AL at baseline, single PANSS
negative items emotional withdrawal (N2) and lack of spontane-
ity (N6) indicated deterioration at trend level in this group. Again,
we noted an effect of AL on negative syndrome scores with a
significant group effect and a group× time interaction at trend
level. Here, patients with higher AL at index episode increased
their negative syndrome scores between episodes. This is particu-
larly interesting as the negative syndrome scores at baseline were
similar between groups. Thus, only our measure of spontaneous
motor activity had predictive value for negative syndrome scores.
Again, results must be interpreted with caution due to the small
groups.
LIMITATIONS
This was a truly naturalistic study design, which is not able to
detect longitudinal changes associated with specific drug effects.
There are various effects that may have contributed to the observed
changes. Medication may have heterogeneous effects on motor
activity (36). The observation period could not be standardized.
In addition, the sample sizes were small, particularly for the inter-
episode comparison. Thus, we may have missed effects due to
type-II errors. In addition, diagnoses were given after thorough
clinical psychiatric examination and chart review; however, struc-
tured clinical interviews (both SCID and MINI) were only applied
in a proportion of (27% of cases) patients. We assessed negative
symptoms with the PANSS negative syndrome scale and PANSS
factors for avolition and expressivity. Additional negative scales
such as the scale for the assessment of negative symptoms (SANS)
(37) or the clinical assessment interview for negative symptoms
(CAINS) (38) were not applied. Finally, future studies could
include measures of motor syndromes such as catatonia, neurolog-
ical soft signs, and parkinsonism to account for differential effects
of medication on motor signs (30). In sum, we think our results
are encouraging for large randomized controlled trials focusing
on negative symptoms in schizophrenia.
CONCLUSION
Spontaneous gross motor behavior in schizophrenia shares trait
and state characteristics. Within-episodes motor activity varies
with negative syndrome scores, while between psychotic episodes
motor activity remains stable. Wrist actigraphy should be consid-
ered as objective ambulatory non-invasive instrument to monitor
the effects of treatment on negative symptoms.
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